The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse

Cell Metabolism

Volumn 1, Issue 4, 2005, Pages 245-258

  Steneberg, Pär ^a   Rubins, Nir ^b   Bartoov Shifman, Reut ^b   Walker, Michael D ^b   Edlund, Helena ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 40; GLUCOSE; INSULIN; UNCLASSIFIED DRUG; GPR40 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FATTY LIVER; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; HYPOINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; MOUSE; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; GENETICS; HOMEOSTASIS; HYPERINSULINISM; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION;

ANIMALS; DIABETES MELLITUS, TYPE 2; FATTY LIVER; GLUCOSE; GLUCOSE INTOLERANCE; HOMEOSTASIS; HYPERINSULINISM; HYPERTRIGLYCERIDEMIA; INSULIN; ISLETS OF LANGERHANS; MICE; RECEPTORS, G-PROTEIN-COUPLED;

EID: 20944433543     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2005.03.007     Document Type: Article

References (66)

1. Ahren B., Simonsson E., Scheurink A.J., Mulder H., Myrsen U., and Sundler F. Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice. Metabolism 46 (1997) 97-106
2. Apelqvist A., Ahlgren U., and Edlund H. Sonic hedgehog directs specialised mesoderm differentiation in the intestine and pancreas. Curr. Biol. 7 (1997) 801-804
3. Arber S., Han B., Mendelsohn M., Smith M., Jessell T.M., and Sockanathan S. Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity. Neuron 23 (1999) 659-674
4. Assimacopoulos-Jeannet F., Thumelin S., Roche E., Esser V., McGarry J.D., and Prentki M. Fatty acids rapidly induce the carnitine palmitoyltransferase I gene in the pancreatic beta-cell line INS-1. J. Biol. Chem. 272 (1997) 1659-1664
5. Bedoucha M., Atzpodien E., and Boelsterli U.A. Diabetic KKAy mice exhibit increased hepatic PPARgamma1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones. J. Hepatol. 35 (2001) 17-23
6. Bjorklund A., and Grill V. Enhancing effects of long-term elevated glucose and palmitate on stored and secreted proinsulin-to-insulin ratios in human pancreatic islets. Diabetes 48 (1999) 1409-1414
7. Boucher A., Lu D., Burgess S.C., Telemaque-Potts S., Jensen M.V., Mulder H., Wang M.Y., Unger R.H., Sherry A.D., and Newgard C.B. Biochemical mechanism of lipid-induced impairment of glucose-stimulated insulin secretion and reversal with a malate analogue. J. Biol. Chem. 279 (2004) 27263-27271
8. Briscoe C.P., Tadayyon M., Andrews J.L., Benson W.G., Chambers J.K., Eilert M.M., Ellis C., Elshourbagy N.A., Goetz A.S., Minnick D.T., et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J. Biol. Chem. 278 (2003) 11303-11311
9. Chan C.B., MacDonald P.E., Saleh M.C., Johns D.C., Marban E., and Wheeler M.B. Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. Diabetes 48 (1999) 1482-1486
10. Chan C.B., De Leo D., Joseph J.W., McQuaid T.S., Ha X.F., Xu F., Tsushima R.G., Pennefather P.S., Salapatek A.M., and Wheeler M.B. Increased uncoupling protein-2 levels in beta-cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action. Diabetes 50 (2001) 1302-1310
11. Chao L., Marcus-Samuels B., Mason M.M., Moitra J., Vinson C., Arioglu E., Gavrilova O., and Reitman M.L. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. J. Clin. Invest. 106 (2000) 1221-1228
12. Efrat S. Making sense of glucose sensing. Nat. Genet. 17 (1997) 249-250
13. Evans R.M., Barish G.D., and Wang Y.X. PPARs and the complex journey to obesity. Nat. Med. 10 (2004) 1-7
14. Furukawa H., Carroll R.J., Swift H.H., and Steiner D.F. Long-term elevation of free fatty acids leads to delayed processing of proinsulin and prohormone convertases 2 and 3 in the pancreatic beta-cell line MIN6. Diabetes 48 (1999) 1395-1401
15. Gavrilova O., Haluzik M., Matsusue K., Cutson J.J., Johnson L., Dietz K.R., Nicol C.J., Vinson C., Gonzalez F.J., and Reitman M.L. Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J. Biol. Chem. 278 (2003) 34268-34276
16. Gregoire F.M., Zhang Q., Smith S.J., Tong C., Ross D., Lopez H., and West D.B. Diet-induced obesity and hepatic gene expression alterations in C57BL/6J and ICAM-1-deficient mice. Am. J. Physiol. Endocrinol. Metab. 282 (2002) E703-E713
17. Gremlich S., Bonny C., Waeber G., and Thorens B. Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels. J. Biol. Chem. 272 (1997) 30261-30269
18. Guillam M.T., Hummler E., Schaerer E., Yeh J.I., Birnbaum M.J., Beermann F., Schmidt A., Deriaz N., Thorens B., and Wu J.Y. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2. Nat. Genet. 17 (1997) 327-330
19. Haber E.P., Ximenes H.M., Procopio J., Carvalho C.R., Curi R., and Carpinelli A.R. Pleiotropic effects of fatty acids on pancreatic beta-cells. J. Cell. Physiol. 194 (2002) 1-12
20. Haffner S.M., Gonzalez C., Mykkanen L., and Stern M. Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study. Diabetologia 40 (1997) 830-837
21. Hart A.W., Baeza N., Apelqvist A., and Edlund H. Attenuation of FGF signalling in mouse beta-cells leads to diabetes. Nature 408 (2000) 864-868
22. Hirasawa A., Tsumaya K., Awaji T., Katsuma S., Adachi T., Yamada M., Sugimoto Y., Miyazaki S., and Tsujimoto G. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat. Med. 11 (2005) 90-94
23. Hoffmann S., Podlich D., Hahnel B., Kriz W., and Gretz N. Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J. Am. Soc. Nephrol. 15 (2004) 1475-1487
24. Hogan B., Beddington R., Costantini F., and Lacy E. Manipulating the Mouse Embryo (1994), Cold Spring Harbor Laboratory Press, Plainview, New York
25. Iizuka K., Nakajima H., Namba M., Miyagawa J., Miyazaki J., Hanafusa T., and Matsuzawa Y. Metabolic consequence of long-term exposure of pancreatic beta cells to free fatty acid with special reference to glucose insensitivity. Biochim. Biophys. Acta 1586 (2002) 23-31
26. Itoh Y., Kawamata Y., Harada M., Kobayashi M., Fujii R., Fukusumi S., Ogi K., Hosoya M., Tanaka Y., Uejima H., et al. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 42 (2003) 173-176
27. Kahn B.B. Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance. Cell 92 (1998) 593-596
28. Kahn B.B., and Flier J.S. Obesity and insulin resistance. J. Clin. Invest. 4 (2000) 473-481
29. Kahn S.E., Leonetti D.L., Prigeon R.L., Boyko E.J., Bergstrom R.W., and Fujimoto W.Y. Proinsulin as a marker for the development of NIDDM in Japanese-American men. Diabetes 44 (1995) 173-179
30. Kashyap S., Belfort R., Gastaldelli A., Pratipanawatr T., Berria R., Pratipanawatr W., Bajaj M., Mandarino L., DeFronzo R., and Cusi K. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52 (2003) 2461-2474
31. Kim S., Sohn I., Ahn J.I., Lee K.H., Lee Y.S., and Lee Y.S. Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model. Gene 340 (2004) 99-109
32. Kotarsky K., Nilsson N.E., Flodgren E., Owman C., and Olde B. A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs. Biochem. Biophys. Res. Commun. 301 (2003) 406-410
33. Lameloise N., Muzzin P., Prentki M., and Assimacopoulos-Jeannet F. Uncoupling protein 2: a possible link between fatty acid excess and impaired glucose-induced insulin secretion?. Diabetes 50 (2001) 803-809
34. Larsson H., and Ahren B. Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance. J. Clin. Endocrinol. Metab. 84 (1999) 2068-2074
35. Li L.X., Skorpen F., Egeberg K., Jorgensen I.H., and Grill V. Induction of uncoupling protein 2 mRNA in beta-cells is stimulated by oxidation of fatty acids but not by nutrient oversupply. Endocrinology 143 (2002) 1371-1377
36. Linghor M.K., Buettner R., and Rhodes C.J. Pancreatic beta-cell growth and survival-a role in obesity-linked type 2 diabetes?. Trends Mol. Med. 8 (2002) 375-384
37. Liu Y.Q., Tornheim K., and Leahy J.L. Glucose-fatty acid cycle to inhibit glucose utilization and oxidation is not operative in fatty acid-cultured islets. Diabetes 48 (1999) 1747-1753
38. 2 in the modulation of insulin secretion. Am. J. Physiol. Endocrinol. Metab. 286 (2004) E560-E567
39. Malone M.H., Wang Z., and Distelhorst C.W. The glucocorticoid-induced gene tdag8 encodes a pro-apoptotic G protein-coupled receptor whose activation promotes glucocorticoid-induced apoptosis. J. Biol. Chem. 279 (2004) 52850-52859. 10.1074/jbc.M408040200 Published online October 12, 2004
40. Matsusue K., Haluzik M., Lambert G., Yim S.H., Gavrilova O., Ward J.M., Brewer Jr. B., Reitman M.L., and Gonzalez F.J. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J. Clin. Invest. 111 (2003) 737-747
41. Memon R.A., Tecott L.H., Nonogaki K., Beigneux A., Moser A.H., Grunfeld C., and Feingold K.R. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinology 141 (2000) 4021-4031
42. Miyake K., Ogawa W., Matsumoto M., Nakamura T., Sakaue H., and Kasuga M. Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver. J. Clin. Invest. 110 (2002) 1483-1491
43. Moller D.E., and Kaufman K.D. Metabolic syndrome: a clinical and molecular perspective. Annu. Rev. Med. 56 (2005) 45-62
44. Nijpels G., Popp-Snijders C., Kostense P.J., Bouter L.M., and Heine R.J. Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study. Diabetologia 39 (1996) 113-118
45. Patanè G., Anello M., Piro S., Vigneri R., Purrello F., and Rabuazzo A.M. Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-gamma inhibition. Diabetes 51 (2002) 2749-2756
46. Rahimian R., Masih-Khan E., Lo M., van Breemen C., McManus B.M., and Dube G.P. Hepatic over-expression of peroxisome proliferator activated receptor gamma2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus. Mol. Cell. Biochem. 224 (2001) 29-37
47. Rossmeisl M., Rim J.S., Koza R.A., and Kozak L.P. Variation in type 2 diabetes-related traits in mouse strains susceptible to diet-induced obesity. Diabetes 52 (2003) 1958-1966
48. Rubí B., Antinozzi P.A., Herrero L., Ishihara H., Asins G., Serra D., Wollheim C.B., Maechler P., and Hegardt F.G. Adenovirus-mediated overexpression of liver carnitine palmitoyltransferase I in INS1E cells: effects on cell metabolism and insulin secretion. Biochem. J. 364 (2002) 219-226
49. Schaffer J.E. Fatty acid transport: the roads taken. Am. J. Physiol. Endocrinol. Metab. 282 (2002) E239-E246
50. Segall L., Lameloise N., Assimacopoulos-Jeannet F., Roche E., Corkey P., Thumelin S., Corkey B.E., and Prentki M. Lipid rather than glucose metabolism is implicated in altered insulin secretion caused by oleate in INS-1 cells. Am. J. Physiol. 277 (1999) E521-E528
51. Shimabukuro M., Wang M.Y., Zhou Y.T., Newgard C.B., and Unger R.H. Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression. Proc. Natl. Acad. Sci. USA 95 (1998) 9558-9561
52. Taylor S.I. Deconstructing type 2 diabetes. Cell 97 (1999) 9-12
53. Taylor I.C., Roy S., and Varmus H.E. Overexpression of the Sky receptor tyrosine kinase at the cell surface or in the cytoplasm results in ligand-independent activation. Oncogene 11 (1995) 2619-2626
54. Tordjman K., Standley K.N., Bernal-Mizrachi C., Leone T.C., Coleman T., Kelly D.P., and Semenkovich C.F. PPARalpha suppresses insulin secretion and induces UCP2 in insulinoma cells. J. Lipid Res. 43 (2002) 936-943
55. Unger R.H. The physiology of cellular liporegulation. Annu. Rev. Physiol. 65 (2002) 333-347
56. Wang M.Y., Koyama K., Shimabukuro M., Mangelsdorf D., Newgard C.B., and Unger R.H. Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion. Proc. Natl. Acad. Sci. USA 95 (1998) 11921-11926
57. Wolfrum C., Asilmaz E., Luca E., Friedman J.M., and Stoffel M. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature 23 (2004) 1027-1032
58. Yamagata K., Nammo T., Moriwaki M., Ihara A., Iizuka K., Yang Q., Satoh T., Li M., Uenaka R., Okita K., et al. Overexpression of dominant-negative mutant hepatocyte nuclear fctor-1 alpha in pancreatic beta-cells causes abnormal islet architecture with decreased expression of E-cadherin, reduced beta-cell proliferation, and diabetes. Diabetes 51 (2002) 114-123
59. Yaney G.C., and Corkey B.E. Fatty acid metabolism and insulin secretion in pancreatic beta cells. Diabetologia 46 (2003) 1297-1312
60. Yu S., Matsusue K., Kashireddy P., Cao W.Q., Yeldandi V., Yeldandi A.V., Rao M.S., Gonzalez F.J., and Reddy J.K. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J. Biol. Chem. 278 (2003) 498-505
61. Zhang C.Y., Baffy G., Perret P., Krauss S., Peroni O., Grujic D., Hagen T., Vidal-Puig A.J., Boss O., Kim Y.B., et al. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 105 (2001) 745-755
62. Zhou Y.P., and Grill V.E. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J. Clin. Invest. 93 (1994) 870-876
63. Zhou Y.P., and Grill V.E. Palmitate-induced beta-cell insensitivity to glucose is coupled to decreased pyruvate dehydrogenase activity and enhanced kinase activity in rat pancreatic islets. Diabetes 44 (1995) 394-399
64. Zhou Y.P., Priestman D.A., Randle P.J., and Grill V.E. Fasting and decreased B cell sensitivity: important role for fatty acid-induced inhibition of PDH activity. Am. J. Physiol. 270 (1996) E988-E994
65. Zhou Y.T., Shimabukuro M., Wang M.Y., Lee Y., Higa M., Milburn J.L., Newgard C.B., and Unger R.H. Role of peroxisome proliferator-activated receptor alpha in disease of pancreatic beta cells. Proc. Natl. Acad. Sci. USA 95 (1998) 8898-8903
66. Zraika S., Dunlop M., Proietto J., and Anrikopoulos S. Effects of free fatty acids on insulin secretion in obesity. Obes. Rev. 3 (2002) 103-112